Salvage endoscopic resection after definitive chemoradiotherapy for esophageal cancer: a Western experience
Definitive chemoradiotherapy is increasingly used as a nonsurgical treatment for esophageal cancer. Salvage endoscopic resection has emerged as a promising strategy for local failure after definitive CRT. During a median of 24 months of follow-up after salvage ER, 52% developed a recurrence. No major intra- or postprocedural adverse events such as bleeding or perforation were reported.
